Covidien Stock To Go Ex-dividend Monday (COV)

NEW YORK ( TheStreet) -- The ex-dividend date for Covidien (NYSE: COV) is Monday, April 2, 2012. Owners of shares as of market close today will be eligible for a dividend of 23 cents per share. At a price of $54.25 as of 9:30 a.m. ET, the dividend yield is 1.7%.

The average volume for Covidien has been 3.5 million shares per day over the past 30 days. Covidien has a market cap of $23.59 billion and is part of the health care sector and health services industry. Shares are up 19.8% year to date as of the close of trading on Thursday.

Covidien Public Limited Company develops, manufactures, and sells healthcare products for use in clinical and home settings in the United States and internationally. The company has a P/E ratio of 13.7, above the average health services industry P/E ratio of 13 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, notable return on equity, attractive valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Covidien Ratings Report.

See our dividend calendar or top-yielding stocks list.
null

If you liked this article you might like

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Mallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment Deal

Stryker and Smith & Nephew Are the Stars to Watch in Medtech's 2015 Merger Dance

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Trim Positions in Stryker Ahead of Fourth-Quarter Earnings; Buy on Pullback